Talks between Bayer AG and plaintiff lawyers to settle claims that the German company’s glyphosate-based weedkillers cause cancer have been slowed by the coronavirus pandemic, Bayer’s Chief Executive told daily Handelsblatt.
“This is about currently not being able to meet in person for talks. All this of course slows down the negotiations,” CEO Werner Baumann told the newspaper in an interview published on Thursday.
Court-appointed mediator Ken Feinberg told Reuters last month that the talks were slowed by the pandemic.
In the Handelsblatt interview, CEO Baumann reiterated remarks he made at the end of February that he was under no time pressure to strike a settlement deal and that he would not submit to a schedule or deadline.
(Reporting by Ludwig Burger and Patricia Weiss Editing by Michelle Martin)
Was this article valuable?
Here are more articles you may enjoy.
Tech and Finance Sectors Losing 28,000 Jobs Monthly Show AI Impact on Labor 
国产一福利 Change Keeps Adding to List of Uninsurable Assets, Allianz Executive Says 
PE-Backed Insurance Broker Hub International Files Confidentially for US IPO 
Ford’s AI Hiccups Lead Carmaker to Rehire ‘Gray Beard’ Engineers 
